Page last updated: 2024-10-31

metyrapone and Aesthesioneuroblastoma

metyrapone has been researched along with Aesthesioneuroblastoma in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kadoya, M1
Kurajoh, M1
Miyoshi, A1
Shoji, T1
Terada, T1
Nakamoto, Y1
Tsukamoto, Y1
Moriwaki, Y1
Hirota, S1
Koyama, H1

Other Studies

1 other study available for metyrapone and Aesthesioneuroblastoma

ArticleYear
Ectopic adrenocorticotropic hormone syndrome associated with olfactory neuroblastoma: acquirement of adrenocorticotropic hormone expression during disease course as shown by serial immunohistochemistry examinations.
    The Journal of international medical research, 2018, Volume: 46, Issue:11

    Topics: Adrenocorticotropic Hormone; Blood Glucose; Disease Progression; Eosinophils; Esthesioneuroblastoma,

2018